|
WO2021064580A1
|
|
Controlled release injectable ondansetron formulations
|
|
WO2021044328A1
|
|
Cabazitaxel liquid formulations
|
|
WO2021009605A1
|
|
Dispersible tablets of abiraterone acetate
|
|
EP3747428A1
|
|
Stable melphalan liquid injectable formulations
|
|
WO2020170104A1
|
|
Liquid bendamustine parenteral compositions
|
|
WO2020141404A1
|
|
Green tea film composition
|
|
WO2020084416A1
|
|
Spray compositions of chitosan for wound healing
|
|
EP3801560A1
|
|
Pharmaceutical compositions of decitabine
|
|
CN111065384A
|
|
Composition of orally disintegrating film of paracetamol
|
|
EP3784286A1
|
|
Ophthalmic compositions of brinzolamide
|
|
US2019275026A1
|
|
Pharmaceutical compositions of lenvatinib
|
|
WO2019166926A2
|
|
Methotrexate ophthalmic solution
|
|
US2021060017A1
|
|
Methotrexate ophthalmic solution
|
|
US2020339588A1
|
|
Novel polymorphs of ribociclib mono succinate
|
|
WO2019111136A1
|
|
Methotrexate topical solution for treatment of psoriasis
|
|
WO2019106511A1
|
|
Composition of docetaxel liposomal injection with high drug loading
|
|
WO2019082139A1
|
|
Fingolimod hydrochloride liposomal injection
|
|
SG11202001547RA
|
|
Tranexamic acid spray for knee arthroplasty
|
|
WO2019025986A1
|
|
Ophthalmic compositions of cyclosporine
|
|
WO2019008472A1
|
|
Pharmaceutical compositions of lignocaine hcl
|
